← 治験一覧に戻る
膵臓がん検出コンソーシアム
基本情報
- NCT ID
- NCT06388967
- ステータス
- 募集中
- 試験のフェーズ
- -
- 試験タイプ
- 観察
- 目標被験者数
- 2,000
- 治験依頼者名
- City of Hope Medical Center
概要
This study aims to prospective validate an exosome-based miRNA signature for noninvasive and early detection of pancreatic ductal adenocarcinoma.
対象疾患
Pancreatic CancerPancreatic CarcinomaPancreatic AdenocarcinomaPancreatic Ductal AdenocarcinomaPancreatic NeoplasmsPancreatic Cancer Stage IPancreatic Cancer StagePancreatic Cancer ResectablePancreatic Cancer Stage 0Pancreatic Cancer Stage IIPancreatic Cancer Stage IIIPancreatic Cancer, AdultPancreatic Cancer Non-resectable
介入
PANcreatic cancer Exosome Early detectiON (PANXEON)(DIAGNOSTIC_TEST)
依頼者（Sponsor）
City Of Hope Medical Center(OTHER)
実施施設 (1)
日本赤十字社愛知医療センター名古屋第二病院
Nagoya, Japan(RECRUITING)